BLEOMYCIN, ADRIAMYCIN, CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (BACOP) COMBINATION CHEMOTHERAPY IN TREATMENT OF ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA

被引：380

作者：

SCHEIN, PS

DEVITA, VT

HUBBARD, S

CHABNER, BA

CANELLOS, GP

BERARD, C

YOUNG, RC

机构：

[1] NCI, MED BRANCH, BETHESDA, MD 20014 USA

[2] NCI, PATHOL LAB, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-85-4-417

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：417 / 422

页数：6

共 27 条

[21] MCKELVEY EM, 1975, P AM ASSOC CANC RES, V16, P233
[22] Rappaport H., 1966, C SECT 3 FASE, V8, P91
[23] POTENTIAL FOR PROLONGED DISEASE-FREE SURVIVAL FOLLOWING COMBINATION CHEMOTHERAPY OF NON-HODGKINS LYMPHOMA
SCHEIN, PS
CHABNER, BA
CANELLOS, GP
YOUNG, RC
BERARD, C
DEVITA, VT
[J]. BLOOD, 1974, 43 (02) : 181 - 189
[24] SCHEIN PS, 1975, CANCER, V35, P354, DOI 10.1002/1097-0142(197502)35:2<354::AID-CNCR2820350209>3.0.CO
[25] 2-2
[26] SKARIN A, 1974, P AM ASSOC CANC RES, V15, P133
[27] Yates F., 1934, J ROYAL STAT SOC S, V1, P217